Cold Spring Harbor Laboratory: Applying Symptom Tracking to COVID-19 Outpatient Care Using Famotidine
June 05, 2020
June 05, 2020
COLD SPRING HARBOR, New York, June 5 -- The Cold Spring Harbor Laboratory issued the following news:
A patient-reported symptom tracking method used for patients with cancer has now been adapted for patients with COVID-19. Investigating the effect of famotidine, a potential treatment for COVID-19, on non-hospitalized patients with COVID-19, clinicians at Northwell Health and cancer researchers at Cold Spring Harbor Laboratory (CSHL) developed the method to use in addition to laborat . . .
A patient-reported symptom tracking method used for patients with cancer has now been adapted for patients with COVID-19. Investigating the effect of famotidine, a potential treatment for COVID-19, on non-hospitalized patients with COVID-19, clinicians at Northwell Health and cancer researchers at Cold Spring Harbor Laboratory (CSHL) developed the method to use in addition to laborat . . .